Note: registration required (free), discusses Japanese trial with weekly Taxol and increased
overall survival,
GOG 262 ((see arms 1 & 2) etc...
|
Overview:
Dr Bradley Monk very eloquently describes a case of newly diagnosed advanced ovarian cancer and reinforces the importance of debulking surgery and combination chemotherapy. Various therapeutic options and recent clinical trial data are discussed.
Topics:
•
|
Small and large volume residual disease and treatment decision making
|
•
|
Standards and clinical trials
|
•
|
Role of antiangiogenic agents in ovarian cancer management
|
|
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.